Clinical Trial Update: Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial compares once-weekly trelagliptin with once-daily vildagliptin to assess HbA1c reduction in Type 2 diabetes; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Trelagliptin (trelagliptin)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Lahore General Hospital | Conditions: Type 2 Diabetes Mellitus (T2DM) | NA | Status: ACTIVE_NOT_RECRUITING